Drug-target interaction prediction by learning from local information and neighbors

MOTIVATION In silico methods provide efficient ways to predict possible interactions between drugs and targets. Supervised learning approach, bipartite local model (BLM), has recently been shown to be effective in prediction of drug-target interactions. However, for drug-candidate compounds or target-candidate proteins that currently have no known interactions available, its pure 'local' model is not able to be learned and hence BLM may fail to make correct prediction when involving such kind of new candidates. RESULTS We present a simple procedure called neighbor-based interaction-profile inferring (NII) and integrate it into the existing BLM method to handle the new candidate problem. Specifically, the inferred interaction profile is treated as label information and is used for model learning of new candidates. This functionality is particularly important in practice to find targets for new drug-candidate compounds and identify targeting drugs for new target-candidate proteins. Consistent good performance of the new BLM-NII approach has been observed in the experiment for the prediction of interactions between drugs and four categories of target proteins. Especially for nuclear receptors, BLM-NII achieves the most significant improvement as this dataset contains many drugs/targets with no interactions in the cross-validation. This demonstrates the effectiveness of the NII strategy and also shows the great potential of BLM-NII for prediction of compound-protein interactions. CONTACT jpmei@ntu.edu.sg SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.

[1]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[2]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[3]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[4]  Xiaobo Zhou,et al.  Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.

[5]  Robert B. Russell,et al.  SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..

[6]  Yoshihiro Yamanishi,et al.  Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..

[7]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[8]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[9]  Antje Chang,et al.  New Developments , 2003 .

[10]  Bryan L. Roth,et al.  Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.

[11]  Roded Sharan,et al.  Combining Drug and Gene Similarity Measures for Drug-Target Elucidation , 2011, J. Comput. Biol..

[12]  K. Chou,et al.  Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.

[13]  Y. Martin,et al.  Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.

[14]  M. Kanehisa,et al.  Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. , 2003, Journal of the American Chemical Society.

[15]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[16]  Mark Goadrich,et al.  The relationship between Precision-Recall and ROC curves , 2006, ICML.

[17]  Michael Schroeder,et al.  Old friends in new guise: repositioning of known drugs with structural bioinformatics , 2011, Briefings Bioinform..

[18]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[19]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.